Atlas Trials

Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

Clinical trial NCT02891811 · COMPLETED

Trial details

NCT number
NCT02891811
Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2017-03-10
Primary completion
2024-03-28
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.